LONDON (AP) — Only about half of the cancer drugs approved by the European Medicines Agency in the last few years were later shown to help patients live longer or improved their lives, a new study says. Scientists in Britain and Latvia analyzed reports from the European regulator on cancer approvals from 2009 to 2013.…